首页> 外文期刊>Journal of Cancer Research and Therapeutics >Analysis of patient specific dosimetry quality assurance measurements in intensity modulated radiotherapy: A multi centre study
【24h】

Analysis of patient specific dosimetry quality assurance measurements in intensity modulated radiotherapy: A multi centre study

机译:调强放疗中患者特定剂量学质量保证测量的分析:多中心研究

获取原文
获取外文期刊封面目录资料

摘要

Aim of the Study: Statistical analysis of pre-treatment dose verification of intensity-modulated radiotherapy (IMRT) fields to assess the quality of the IMRT practice at different radiotherapy centers. Materials and Methods: The dose verification data acquired by the institutional physicist of 10 different hospitals for various types of patients were collected and analyzed for mean, median, standard deviation (SD), range, minimum and maximum % deviation. The percentage of cases having positive and negative dose differences as well dose differences within ± 3% were also determined. Results: The mean values of percentage variation in difference between treatment planning systems calculated dose and difference between measured dose (D TPS and D Meas ) are found to be from – 1.79 to 1.48 and median from – 1.79 to 1.51. The SDs are found to be from 0.76 to 3.70. The range of variation at these centers varies from 3.99 to 16.45 while minimum and maximum values of percentage variation in difference between D TPS and D Meas ranges from – 10.33 to 13.38. The percentage of cases having positive dose difference ranges from 8 to 94 and cases having negative dose difference ranges from 6 to 92. The percentage of cases having dose difference within ± 3% varies from 57 to 100. Conclusion: IMRT centers are having random and biased (skewed towards over or under dose) distribution of the percentage variation in difference between measured and planned doses. The analysis of results of the IMRT pre-treatment dose verification reveals that there are systematic errors in the chain of IMRT treatment process at a few centers. The dosimetry quality audit prior to commissioning of IMRT may play an important role in avoiding such discrepancies.
机译:研究的目的:对调强放疗(IMRT)领域进行治疗前剂量验证的统计分析,以评估不同放疗中心的IMRT实践质量。材料和方法:收集10家不同医院的机构物理学家针对各种类型患者获得的剂量验证数据,并分析其平均值,中位数,标准差(SD),范围,最小和最大%偏差。还确定了阳性和阴性剂量差异以及剂量差异在±3%以内的病例百分比。结果:发现治疗计划系统计算剂量之间的差异与测量剂量之间的差异(D TPS 和D Meas )之间的百分比变化的平均值为– 1.79至1.48,中位数从– 1.79到1.51。发现SD为0.76至3.70。这些中心的变化范围从3.99到16.45,而D TPS 和D Meas 之间的差异百分比变化的最大值和最小值在– 10.33至13.38之间。剂量差异为正的病例百分比为8到94,剂量差异为负的病例百分比为6至92。剂量差异在±3%以内的病例百分比为57到100。结论:IMRT中心具有随机性和测量剂量与计划剂量之间的差异百分比变化有偏差(偏向剂量偏高或偏低)。对IMRT预处理剂量验证结果的分析表明,在一些中心的IMRT治疗过程链中存在系统性错误。 IMRT调试之前的剂量学质量审核可能在避免此类差异方面发挥重要作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号